<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress.com" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>drug-market-info &amp;laquo; WordPress.com Tag Feed</title>
	<link>http://en.wordpress.com/tag/drug-market-info/</link>
	<description>Feed of posts on WordPress.com tagged "drug-market-info"</description>
	<pubDate>Sun, 19 May 2013 21:14:38 +0000</pubDate>

	<generator>http://en.wordpress.com/tags/</generator>
	<language>en</language>

<item>
<title><![CDATA[Leading Researcher Expounds on Faster FDA Approvals - Notes &amp; Notable on Oncology Drug Approvals]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/12/12/leading-researcher-expounds-on-faster-fda-approvals-notes-notable-on-oncology-drug-approvals/</link>
<pubDate>Wed, 12 Dec 2012 05:45:43 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/12/12/leading-researcher-expounds-on-faster-fda-approvals-notes-notable-on-oncology-drug-approvals/</guid>
<description><![CDATA[Drug Market Info presents Notes &amp; Notable, an interview series with leading voices in the field.]]></description>
<content:encoded><![CDATA[Drug Market Info presents Notes &amp; Notable, an interview series with leading voices in the field.]]></content:encoded>
</item>
<item>
<title><![CDATA[Psoriatic Arthritis Notes and Notable: Dr. M. Elaine Husni on PsA vs RA – Why More Clinical Trials Are Needed]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/11/07/psoriatic-arthritis-notes-and-notable-dr-m-elaine-husni-on-psa-vs-ra-why-more-clinical-trials-are-needed/</link>
<pubDate>Wed, 07 Nov 2012 15:11:44 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/11/07/psoriatic-arthritis-notes-and-notable-dr-m-elaine-husni-on-psa-vs-ra-why-more-clinical-trials-are-needed/</guid>
<description><![CDATA[Drug Market Info presents Psoriatic Arthritis Notes &amp; Notable, an interview series with leading]]></description>
<content:encoded><![CDATA[Drug Market Info presents Psoriatic Arthritis Notes &amp; Notable, an interview series with leading]]></content:encoded>
</item>
<item>
<title><![CDATA[Psoriasis Notes and Notable – Dr. Steven Feldman on Biologics, Topicals, Adherence and Treatment]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/10/24/psoriasis-notes-and-notable-dr-steven-feldman-on-biologics-topicals-adherence-and-treatment/</link>
<pubDate>Wed, 24 Oct 2012 15:58:39 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/10/24/psoriasis-notes-and-notable-dr-steven-feldman-on-biologics-topicals-adherence-and-treatment/</guid>
<description><![CDATA[Drug Market Info presents Psoriasis Notes &amp; Notable, an interview series with leading voices in]]></description>
<content:encoded><![CDATA[Drug Market Info presents Psoriasis Notes &amp; Notable, an interview series with leading voices in]]></content:encoded>
</item>
<item>
<title><![CDATA[Prostate Cancer Notes and Notable – Dr. Judd W Moul: Part 2 - Sequencing and Prostate Cancer Treatment]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/10/10/prostate-cancer-notes-and-notable-dr-judd-w-moul-part-2-sequencing-and-prostate-cancer-treatment/</link>
<pubDate>Wed, 10 Oct 2012 15:47:32 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/10/10/prostate-cancer-notes-and-notable-dr-judd-w-moul-part-2-sequencing-and-prostate-cancer-treatment/</guid>
<description><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></description>
<content:encoded><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></content:encoded>
</item>
<item>
<title><![CDATA[Prostate Cancer Notes and Notable – Dr. Judd W Moul: Part 1 - A Leading Clinician’s View on Zytiga® and Xtandi®]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/09/22/prostate-cancer-notes-and-notable-dr-judd-w-moul-part-1-a-leading-clinicians-view-on-zytiga-and-xtandi/</link>
<pubDate>Sat, 22 Sep 2012 21:05:21 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/09/22/prostate-cancer-notes-and-notable-dr-judd-w-moul-part-1-a-leading-clinicians-view-on-zytiga-and-xtandi/</guid>
<description><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></description>
<content:encoded><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></content:encoded>
</item>
<item>
<title><![CDATA[Mary Beth Cicero: Why I'm Walking in the Great Strides Walk for Cystic Fibrosis May 20]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/05/18/mary-beth-cicero-why-im-walking-in-the-great-strides-walk-for-cystic-fibrosis-may-20/</link>
<pubDate>Fri, 18 May 2012 18:11:52 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/05/18/mary-beth-cicero-why-im-walking-in-the-great-strides-walk-for-cystic-fibrosis-may-20/</guid>
<description><![CDATA[May is Cystic Fibrosis Awareness Month and one of the largest national fundraising events takes plac]]></description>
<content:encoded><![CDATA[May is Cystic Fibrosis Awareness Month and one of the largest national fundraising events takes plac]]></content:encoded>
</item>
<item>
<title><![CDATA[Prostate Cancer Notes and Notable – Dr. Tomasz Beer, co-author of Cancer Clinical Trials: A Commonsense Guide to Experimental Cancer Therapies and Clinical Trials]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/05/18/prostate-cancer-notes-and-notable-dr-tomasz-beer-co-author-of-cancer-clinical-trials-a-commonsense-guide-to-experimental-cancer-therapies-and-clinical-trials/</link>
<pubDate>Fri, 18 May 2012 13:47:48 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/05/18/prostate-cancer-notes-and-notable-dr-tomasz-beer-co-author-of-cancer-clinical-trials-a-commonsense-guide-to-experimental-cancer-therapies-and-clinical-trials/</guid>
<description><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></description>
<content:encoded><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></content:encoded>
</item>
<item>
<title><![CDATA[Prostate Cancer Notes and Notable – Dr. Tomasz Beer, Chair for Prostate Cancer Research Deputy Director, OHSU Knight Cancer Institute]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/05/17/prostate-cancer-notes-and-notable-dr-tomasz-beer-chair-for-prostate-cancer-research-deputy-director-ohsu-knight-cancer-institute/</link>
<pubDate>Thu, 17 May 2012 15:42:36 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/05/17/prostate-cancer-notes-and-notable-dr-tomasz-beer-chair-for-prostate-cancer-research-deputy-director-ohsu-knight-cancer-institute/</guid>
<description><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></description>
<content:encoded><![CDATA[Drug Market Info presents Prostate Cancer Notes &amp; Notable, an interview series with leading voic]]></content:encoded>
</item>
<item>
<title><![CDATA[Cystic Fibrosis Notes and Notable – Dr. Brian O’Sullivan, Cystic Fibrosis Center Director, UMass Memorial Medical Center ]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/05/01/cystic-fibrosis-notes-and-notable-dr-brian-osullivan-cystic-fibrosis-center-director-umass-memorial-medical-center/</link>
<pubDate>Tue, 01 May 2012 13:59:14 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/05/01/cystic-fibrosis-notes-and-notable-dr-brian-osullivan-cystic-fibrosis-center-director-umass-memorial-medical-center/</guid>
<description><![CDATA[Drug Market Info presents Cystic Fibrosis Notes &amp; Notable, an interview series with leading voic]]></description>
<content:encoded><![CDATA[Drug Market Info presents Cystic Fibrosis Notes &amp; Notable, an interview series with leading voic]]></content:encoded>
</item>
<item>
<title><![CDATA[Cystic Fibrosis Notes and Notable – Robert K. Coughlin, President &amp; CEO, Massachusetts Biotechnology Council]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/04/30/cystic-fibrosis-notes-and-notables-robert-k-coughlin-president-ceo-massachusetts-biotechnology-council/</link>
<pubDate>Mon, 30 Apr 2012 12:45:04 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/04/30/cystic-fibrosis-notes-and-notables-robert-k-coughlin-president-ceo-massachusetts-biotechnology-council/</guid>
<description><![CDATA[Drug Market Info presents Cystic Fibrosis Notes &amp; Notable, an interview series with leading voic]]></description>
<content:encoded><![CDATA[Drug Market Info presents Cystic Fibrosis Notes &amp; Notable, an interview series with leading voic]]></content:encoded>
</item>
<item>
<title><![CDATA[How "The Patients' Perspective" Helped Abbott Make Humira #1 Drug Worldwide]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/04/19/how-the-patients-perspective-helped-abbott-make-humira-1-drug-worldwide/</link>
<pubDate>Thu, 19 Apr 2012 20:00:48 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/04/19/how-the-patients-perspective-helped-abbott-make-humira-1-drug-worldwide/</guid>
<description><![CDATA[Humira is an exemplary example of how listening to your customers and the market makes a difference.]]></description>
<content:encoded><![CDATA[Humira is an exemplary example of how listening to your customers and the market makes a difference.]]></content:encoded>
</item>
<item>
<title><![CDATA[Prostate Cancer Fact Sheet]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/04/03/prostate-cancer-fact-sheet/</link>
<pubDate>Tue, 03 Apr 2012 15:23:47 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/04/03/prostate-cancer-fact-sheet/</guid>
<description><![CDATA[Looking for the facts about Prostate Cancer and the rapidly growing Prostate Cancer market? The foll]]></description>
<content:encoded><![CDATA[Looking for the facts about Prostate Cancer and the rapidly growing Prostate Cancer market? The foll]]></content:encoded>
</item>
<item>
<title><![CDATA[Drug Market Info Launches New Prostate Cancer Market Info™]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/03/27/drug-market-info-launches-new-prostate-cancer-market-info/</link>
<pubDate>Tue, 27 Mar 2012 12:45:55 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/03/27/drug-market-info-launches-new-prostate-cancer-market-info/</guid>
<description><![CDATA[DRUG MARKET INFO LAUNCHES NEW PROSTATE CANCER MARKET INFO™    Comprehensive Presentation-ready Repor]]></description>
<content:encoded><![CDATA[DRUG MARKET INFO LAUNCHES NEW PROSTATE CANCER MARKET INFO™    Comprehensive Presentation-ready Repor]]></content:encoded>
</item>
<item>
<title><![CDATA[Why do a Market Info Report on Cystic Fibrosis?]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/01/30/why-do-a-market-info-report-on-cystic-fibrosis/</link>
<pubDate>Mon, 30 Jan 2012 16:05:52 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/01/30/why-do-a-market-info-report-on-cystic-fibrosis/</guid>
<description><![CDATA[With all of the therapeutic areas where we could focus, I guess the natural question comes up why Dr]]></description>
<content:encoded><![CDATA[With all of the therapeutic areas where we could focus, I guess the natural question comes up why Dr]]></content:encoded>
</item>
<item>
<title><![CDATA[Top Three Trends in Pharma Marketing for 2012]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/01/23/top-three-trends-in-pharma-marketing-for-2012/</link>
<pubDate>Tue, 24 Jan 2012 01:08:32 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/01/23/top-three-trends-in-pharma-marketing-for-2012/</guid>
<description><![CDATA[As part of PharmaVOICE Magazine&#8217;s year-end issue, they asked a selection of industry experts t]]></description>
<content:encoded><![CDATA[As part of PharmaVOICE Magazine&#8217;s year-end issue, they asked a selection of industry experts t]]></content:encoded>
</item>
<item>
<title><![CDATA[Why we produced our PsA Report: too few clinical trials, diagnostic tools or programs to help patients stay on therapy]]></title>
<link>http://drugmarketinfo.wordpress.com/2012/01/04/why-we-produced-our-psa-report-too-few-clinical-trials-diagnostic-tools-or-programs-to-help-patients-stay-on-therapy/</link>
<pubDate>Wed, 04 Jan 2012 20:24:56 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2012/01/04/why-we-produced-our-psa-report-too-few-clinical-trials-diagnostic-tools-or-programs-to-help-patients-stay-on-therapy/</guid>
<description><![CDATA[When we first started selecting the reports for Drug Market Info we naturally chose psoriasis. We ha]]></description>
<content:encoded><![CDATA[When we first started selecting the reports for Drug Market Info we naturally chose psoriasis. We ha]]></content:encoded>
</item>
<item>
<title><![CDATA[Drug Market Info Launches Presentation-Ready Report on Cystic Fibrosis Market ]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/12/08/drug-market-info-launches-presentation-ready-report-on-cystic-fibrosis-market/</link>
<pubDate>Thu, 08 Dec 2011 18:07:40 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/12/08/drug-market-info-launches-presentation-ready-report-on-cystic-fibrosis-market/</guid>
<description><![CDATA[Unique Cystic Fibrosis Market Info™ Report Focuses on Treatment of Orphan Disease from the Patients’]]></description>
<content:encoded><![CDATA[Unique Cystic Fibrosis Market Info™ Report Focuses on Treatment of Orphan Disease from the Patients’]]></content:encoded>
</item>
<item>
<title><![CDATA[Cystic Fibrosis Fact Sheet]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/11/29/cystic-fibrosis-fact-sheet/</link>
<pubDate>Tue, 29 Nov 2011 18:30:24 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/11/29/cystic-fibrosis-fact-sheet/</guid>
<description><![CDATA[Looking for the facts about Cystic Fibrosis and the Cystic Fibrosis market? The following informatio]]></description>
<content:encoded><![CDATA[Looking for the facts about Cystic Fibrosis and the Cystic Fibrosis market? The following informatio]]></content:encoded>
</item>
<item>
<title><![CDATA[Sunday: LA Premier of I'm Just Like You - Children with Psoriasis]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/10/26/sunday-la-premier-of-im-just-like-you-children-with-psoriasis/</link>
<pubDate>Wed, 26 Oct 2011 19:46:12 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/10/26/sunday-la-premier-of-im-just-like-you-children-with-psoriasis/</guid>
<description><![CDATA[Do you know filmmaker and psoriasis/psoriatic arthritis sufferer Fred Finkelstein? Talk about the pa]]></description>
<content:encoded><![CDATA[Do you know filmmaker and psoriasis/psoriatic arthritis sufferer Fred Finkelstein? Talk about the pa]]></content:encoded>
</item>
<item>
<title><![CDATA[Boston Walk to Cure Psoriasis this Saturday, Oct. 15th ]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/10/12/boston-walk-to-cure-psoriasis-this-saturday-oct-15th/</link>
<pubDate>Wed, 12 Oct 2011 17:14:59 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/10/12/boston-walk-to-cure-psoriasis-this-saturday-oct-15th/</guid>
<description><![CDATA[Join Drug Market Info founder Mary Beth Cicero and walk to raise money for important Psoriasis and P]]></description>
<content:encoded><![CDATA[Join Drug Market Info founder Mary Beth Cicero and walk to raise money for important Psoriasis and P]]></content:encoded>
</item>
<item>
<title><![CDATA[Drug Market Info featured in "Tomorrow's Technologies Today"]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/09/15/drug-market-info-featured-in-tomorrows-technologies-today/</link>
<pubDate>Thu, 15 Sep 2011 20:30:35 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/09/15/drug-market-info-featured-in-tomorrows-technologies-today/</guid>
<description><![CDATA[The University of Manitoba&#8217;s Technology Transfer Office is at the cutting edge, so we&#8217;re]]></description>
<content:encoded><![CDATA[The University of Manitoba&#8217;s Technology Transfer Office is at the cutting edge, so we&#8217;re]]></content:encoded>
</item>
<item>
<title><![CDATA[MarketSense and Drug Market Info to run Hot Topic workshop at LES 2011 in San Diego]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/08/31/marketsense-and-drug-market-info-to-run-hot-topic-workshop-at-les-2011-in-san-diego/</link>
<pubDate>Wed, 31 Aug 2011 11:41:07 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/08/31/marketsense-and-drug-market-info-to-run-hot-topic-workshop-at-les-2011-in-san-diego/</guid>
<description><![CDATA[Getting from Marketing to M&amp;A (The &#8220;New&#8221; Licensing) &#8211; Data Will Prevail! Do yo]]></description>
<content:encoded><![CDATA[Getting from Marketing to M&amp;A (The &#8220;New&#8221; Licensing) &#8211; Data Will Prevail! Do yo]]></content:encoded>
</item>
<item>
<title><![CDATA[Study finds no major heart risk in new psoriasis drugs... or does it?]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/08/24/study-finds-no-major-heart-risk-in-new-psoriasis-drugs-or-does-it/</link>
<pubDate>Wed, 24 Aug 2011 18:50:44 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/08/24/study-finds-no-major-heart-risk-in-new-psoriasis-drugs-or-does-it/</guid>
<description><![CDATA[What are we to make of the recent analysis in The Journal of The American Medical Association (JAMA)]]></description>
<content:encoded><![CDATA[What are we to make of the recent analysis in The Journal of The American Medical Association (JAMA)]]></content:encoded>
</item>
<item>
<title><![CDATA[Drug Market Info Launches Presentation-Ready Reports To Help Companies Understand Specific Disease Markets And What Patients Need]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/08/19/drug-market-info-launches-presentation-ready-reports-to-help-companies-understand-specific-disease-markets-and-what-patients-need/</link>
<pubDate>Fri, 19 Aug 2011 18:03:04 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/08/19/drug-market-info-launches-presentation-ready-reports-to-help-companies-understand-specific-disease-markets-and-what-patients-need/</guid>
<description><![CDATA[Our first press release: &nbsp; Drug Market Info Launches Presentation-Ready Reports To Help Compani]]></description>
<content:encoded><![CDATA[Our first press release: &nbsp; Drug Market Info Launches Presentation-Ready Reports To Help Compani]]></content:encoded>
</item>
<item>
<title><![CDATA[Why did we pick Psoriasis for our first DrugMarketInfo report?]]></title>
<link>http://drugmarketinfo.wordpress.com/2011/06/15/why-did-we-pick-psoriasis-for-our-first-drugmarketinfo-report/</link>
<pubDate>Wed, 15 Jun 2011 19:35:50 +0000</pubDate>
<dc:creator>drugmarketinfo</dc:creator>
<guid>http://drugmarketinfo.wordpress.com/2011/06/15/why-did-we-pick-psoriasis-for-our-first-drugmarketinfo-report/</guid>
<description><![CDATA[We have done extensive work in dermatology and specifically in Psoriasis. Frankly, this disease is o]]></description>
<content:encoded><![CDATA[We have done extensive work in dermatology and specifically in Psoriasis. Frankly, this disease is o]]></content:encoded>
</item>

</channel>
</rss>
